Abstract
One of the major drawbacks to the development of novel vaccines has been the lack of safe yet effective adjuvants. Biphasic lipid vesicles are formulations suitable for the delivery of proteins, peptides and oligo/polynucleotides. They constitute a new class of delivery system into which antigens and adjuvants can be incorporated. The purpose of these studies was to investigate the ability of biphasic lipid vesicles (Vaccine-Targeting Adjuvants - VTA) to induce immune responses to bacterial antigens and to enhance the adjuvant activity of CpG ODNs. Immunization of mice with bacterial antigen and CpG ODNs in saline was not as effective at inducing immune responses as formulation in VTA vesicles. Results showed that formulation of CpG ODN in VTA significantly enhanced its adjuvanticity.
Keywords: Biphasic vesicles, vaccine delivery, CpG oligonucleotides, cellular immunity, recombinant bacterial antigens
Current Drug Delivery
Title: Biphasic Lipid Vesicles as a Subcutaneous Delivery System for Protein Antigens and CpG Oligonucleotides
Volume: 3 Issue: 2
Author(s): Valeria L. Alcon, Maria E. Baca-Estrada, Andrew Potter, Lorne A. Babiuk, Praveen Kumar and Marianna Foldvari
Affiliation:
Keywords: Biphasic vesicles, vaccine delivery, CpG oligonucleotides, cellular immunity, recombinant bacterial antigens
Abstract: One of the major drawbacks to the development of novel vaccines has been the lack of safe yet effective adjuvants. Biphasic lipid vesicles are formulations suitable for the delivery of proteins, peptides and oligo/polynucleotides. They constitute a new class of delivery system into which antigens and adjuvants can be incorporated. The purpose of these studies was to investigate the ability of biphasic lipid vesicles (Vaccine-Targeting Adjuvants - VTA) to induce immune responses to bacterial antigens and to enhance the adjuvant activity of CpG ODNs. Immunization of mice with bacterial antigen and CpG ODNs in saline was not as effective at inducing immune responses as formulation in VTA vesicles. Results showed that formulation of CpG ODN in VTA significantly enhanced its adjuvanticity.
Export Options
About this article
Cite this article as:
Alcon L. Valeria, Baca-Estrada E. Maria, Potter Andrew, Babiuk A. Lorne, Kumar Praveen and Foldvari Marianna, Biphasic Lipid Vesicles as a Subcutaneous Delivery System for Protein Antigens and CpG Oligonucleotides, Current Drug Delivery 2006; 3 (2) . https://dx.doi.org/10.2174/156720106776359212
DOI https://dx.doi.org/10.2174/156720106776359212 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Sphingosine-1-Phosphate in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Mast Cells in Allergic and Inflammatory Diseases
Current Pharmaceutical Design Long Term Safety and Efficacy of Internal Carotid Artery Adventitial Stripping in Carotid Sinus Syndrome
Current Hypertension Reviews Engineered Silver Nanoparticles, A New Nanoweapon Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Recognizing the Leaky Gut as a Trans-diagnostic Target for Neuroimmune Disorders Using Clinical Chemistry and Molecular Immunology Assays
Current Topics in Medicinal Chemistry Celecoxib A Selective COX-2 Inhibitor Mitigates Fibrosis but not Pneumonitis Following Lung Irradiation: A Histopathological Study
Current Drug Therapy Obesity: The Metabolic Disease, Advances on Drug Discovery and Natural Product Research
Current Topics in Medicinal Chemistry Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
Current Vascular Pharmacology Methanobrevibacter smithii Archaeosomes-Entrapped mzNL4-3 Virus-Like Particles Induce Specific T helper 1-Oriented Cellular and Humoral Responses Against HIV-1
Current HIV Research Clear Shot at Primary Aim: Susceptibility of Trypanosoma cruzi Organelles, Structures and Molecular Targets to Drug Treatment
Current Topics in Medicinal Chemistry Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer
Current Cancer Drug Targets Mucosal Transmission of Human Immunodeficiency Virus
Current HIV Research Anthrax Fusion Protein Therapy of Cancer
Current Protein & Peptide Science Scientific and Clinical Challenges in Sepsis
Current Pharmaceutical Design Design and Fabrication of Magnetically Responsive Nanocarriers for Drug Delivery
Current Medicinal Chemistry Cross-talk between Cellular Stress, Cell Cycle and Anticancer Agents: Mechanistic Aspects
Current Medicinal Chemistry - Anti-Cancer Agents G4-Interacting DNA Helicases and Polymerases: Potential Therapeutic Targets
Current Medicinal Chemistry Clarithromycin Induced Psoriasis in a 37-Year Old Man
Current Drug Safety Cardio-Vascular Risks Associated with Clozapine Treatment
Current Psychiatry Reviews Natural, Synthetic and their Combinatorial Nanocarriers Based Drug Delivery System in the Treatment Paradigm for Wound Healing Via Dermal Targeting
Current Pharmaceutical Design